Predict your next investment

Venture Capital

See what CB Insights has to offer

Investments

46

Portfolio Exits

14

About Novel TMT Ventures

Novel TMT Ventures is a British Virgin Islands company which is wholly owned by Novel TMT Investments. Novel TMT is the technology, media and telecom investment arm of the Hong Kong based Novel Group, the diversified investment group of Silas Chou and his family.

Novel TMT Ventures Headquarter Location

Virgin Islands (British)

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Novel TMT Ventures News

WorkClout Announces $2.3M Seed Funding

Apr 8, 2020

WorkClout today announced a seed funding of $2.3M. Spider Capital led this round, with participation from Y Combinator, Liquid 2, Soma Capital, Pioneer Fund, Mehta Ventures, Magic Fund, Oyster Ventures, Novel TMT Ventures, Jude Gomila, Kevin Mahaffey, Alan Rutledge, Yuri Sagalov, Frank Zhang, Jonathan Downey, Jan Senderek, Ben Max Rubinstein, Andy Lam and more. WorkClout is enabling industrial labor to perform to their highest potential. WorkClout is a tool that helps industrial Operations & HR Teams make better decisions to improve production efficiency. WorkClout's SaaS tool to helps industrial labor perform to their highest potential by centralizing on-the-job employee training, troubleshooting, safety/quality procedures, knowledge building, and performance tracking. WorkClout is a Y Combinator company. (c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.

Novel TMT Ventures Investments

46 Investments

Novel TMT Ventures has made 46 investments. Their latest investment was in PredictSpring as part of their Series B on June 6, 2022.

CBI Logo

Novel TMT Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

6/15/2022

Series B

PredictSpring

$16M

No

5

7/28/2021

Series D - II

Bloom & Wild

$41.59M

Yes

3

7/13/2021

Unattributed VC - III

Elevate Brands

No

4

2/25/2021

Unattributed VC

Subscribe to see more

$99M

Subscribe to see more

10

3/28/2019

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/15/2022

7/28/2021

7/13/2021

2/25/2021

3/28/2019

Round

Series B

Series D - II

Unattributed VC - III

Unattributed VC

Series A

Company

PredictSpring

Bloom & Wild

Elevate Brands

Subscribe to see more

Subscribe to see more

Amount

$16M

$41.59M

$99M

$99M

New?

No

Yes

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

5

3

4

10

10

Novel TMT Ventures Portfolio Exits

14 Portfolio Exits

Novel TMT Ventures has 14 portfolio exits. Their latest portfolio exit was EdCast on March 17, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

3/17/2022

Acquired

$99M

3

1/18/2022

Acquired

$99M

3

10/27/2021

IPO

$99M

Public

17

6/7/2021

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

4/21/2021

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

3/17/2022

1/18/2022

10/27/2021

6/7/2021

4/21/2021

Exit

Acquired

Acquired

IPO

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Sources

3

3

17

10

10

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.